Salta al contenuto principale
Passa alla visualizzazione normale.

GIUSEPPE BADALAMENTI

Recent advances in desmoid tumor therapy

  • Autori: Napolitano A.; Mazzocca A.; Ceruso M.S.; Minelli A.; Baldo F.; Badalamenti G.; Silletta M.; Santini D.; Tonini G.; Incorvaia L.; Vincenzi B.
  • Anno di pubblicazione: 2020
  • Tipologia: Articolo in rivista
  • OA Link: http://hdl.handle.net/10447/431352

Abstract

The desmoid tumor is a locally aggressive proliferative disease within the family of soft-tissue sarcomas. Despite its relatively good prognosis, the clinical management of desmoid tumors requires constant multidisciplinary evaluation due to its highly variable clinical behavior. Recently, active surveillance has being regarded as the appropriate strategy at diagnosis, as indolent persistence or spontaneous regressions are not uncommon. Here, we review the most recent advances in desmoid tumor therapy, including low-dose chemotherapy and treatment with tyrosine kinase inhibitors. We also explore the recent improvements in our knowledge of the molecular biology of this disease, which are leading to clinical trials with targeted agents.